FIELD: chemistry; pharmaceutics.
SUBSTANCE: group of inventions relates to the chemical-pharmaceutical industry and is a nebulizer containing a liquid pharmaceutical composition and the composition itself suitable for administration by inhalation, containing a pharmaceutically acceptable diluent and a suspension of particles of 9,10-dimethoxy-2-(2,4,6-trimethylphenylimino)-3-(N-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one (RPL554) or a pharmaceutically acceptable salt thereof, wherein RPL554 particles have a particle size distribution with a Dv50 value of 0.2 to about 5 mcm. Inventions also include a method of treating or preventing respiratory diseases.
EFFECT: suspension of particles RPL554 possesses improved pharmacokinetic properties, stability, provides delayed release profile as compared to composition RPL554 in form of solution.
21 cl, 3 dwg, 27 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITIONS CONTAINING RPL554 IN HFA-134A FOR ADMINISTRATION BY INHALATION | 2019 |
|
RU2813959C2 |
DRUG COMBINATION | 2014 |
|
RU2666624C2 |
PHARMACEUTICAL COMPOSITION CONTAINING ENSIFENTRINE | 2020 |
|
RU2825334C2 |
NEW TREATMENT | 2015 |
|
RU2688191C2 |
INHALATION COMPOSITION CONTAINING SULFOALKYL ETHER | 2004 |
|
RU2388462C2 |
AQUEOUS AEROSOL PREPARATION | 2004 |
|
RU2363449C2 |
OXICODON AND NALOXON-CONTAINING PHARMACEUTICAL COMPOSITIONS WITH INSTANT RELEASE | 2010 |
|
RU2522212C2 |
INHALATION FORMULATION CONTAINING SULFOALKYL ETHER GAMMA-CYCLODEXTRIN AND CORTICOSTEROID | 2004 |
|
RU2390330C2 |
SET FOR PHARMACEUTICAL COMPOSITION PREPARING | 2002 |
|
RU2279292C2 |
ARIPIPRAZOLE PRODRUG COMPOSITIONS | 2015 |
|
RU2817019C2 |
Authors
Dates
2019-09-12—Published
2015-09-15—Filed